The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.
Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.
Kauvery Hospital, Alwarpet, successfully treated 54-year-old woman who was admitted with a life-threatening bleed in the ...